UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004088
Receipt number R000004854
Scientific Title Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC
Date of disclosure of the study information 2010/08/27
Last modified on 2018/09/21 09:45:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC

Acronym

Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC

Scientific Title

Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC

Scientific Title:Acronym

Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC

Region

Japan


Condition

Condition

Chronic hepatitis C

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Negative result of HCV RNA test at 24 weeks after terminating therapy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

PEG-IFN alfa2a weekly for 24weeks in patients with negative results of HCV RNA test at week4 of therapy (GroupA)

Interventions/Control_2

PEG-IFN alfa2a weekly for 48weeks in patients with negative results of HCV RNA test at week12 of therapy (GroupB)

Interventions/Control_3

PEG-IFN alfa2a weekly for 72weeks in patients with negative results of HCV RNA test at week36 of therapy (GroupC)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

The following patients with chronic hepatitis C were eligible to enter the trial
1) The patients were hemodialysis at least 3months and had detectable HCV RNA
2)Serogroup doesn't ask it
3)Neutrophil count >=1,500/mm3.Hemoglobin concentration >10g/dL.Platelet count >=90,000/mm3
4) The presence of the liver biopsy is not asked
5) From 18 years old or over to 70years old or less
6)Patients who provided written informed consents to participate the study prior to enrollment

Key exclusion criteria

The following patients were excluded
1)Allegic history to interferon preparations
2)Autoimmune hepatitis,alcoholic liver injury,or chronic liver diseases with other underlying causes
3)Liver cirrhosis,decompensated liver diseases
4) Abnormal thyroid function
5)Concomitant herbal medication of Sho-saikoto
6) history of interstitial pneumonia
7) Women of childbearing potential and pregnancy, lactating woman
8)severe depression
9)Allergic to vaccine or biological preparations
10)Other conditions considered inappropriate by attending physician

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Mochida

Organization

Saitama Medical University

Division name

Division of Gastroenterology and Hepatology,internal Medicine

Zip code


Address

38,Morohongou,Moroyama-cho,Iruma-gun,Saitama,Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Saitama Medical University

Division name

Division of Gastroenterology and Hepatology,internal Medicine

Zip code


Address

38,Morohongou,Moroyama-cho,Iruma-gun,Saitama,Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学病院(埼玉県)、おおしまクリニック(埼玉県)、かみのクリニック(埼玉県)、クボジマクリニック(埼玉県)、くまがやクリニック(埼玉県)、こいづかクリニック(埼玉県)、さやま腎クリニック(埼玉県)、シャローム鋤柄医院(埼玉県)、越生メディカルクリニック(埼玉県)、岡村記念クリニック(埼玉県)、岡病院(埼玉県)、寄居本町クリニック(埼玉県)、高坂医院(埼玉県)、小川病院(埼玉県)、松本クリニック(埼玉県)、池袋病院(埼玉県)、東松山メディカルクリニック(埼玉県)、東松山宏仁クリニック(埼玉県)、東飯能駅前クリニック(埼玉県)、関越病院(埼玉県)、南町クリニック(埼玉県)、入間駅前クリニック(埼玉県)、入間台クリニック(埼玉県)、武蔵嵐山病院(埼玉県)、若葉内科クリニック(埼玉県)


Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 07 Month 12 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 08 Month 24 Day

Last modified on

2018 Year 09 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004854


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name